NRC expected to issue Mo-99 facility license for Shine in 2021
Shine Medical Technologies, which is building a medical isotope production facility in Janesville, Wis., said on May 11 that it expects to have an operating license issued by the Nuclear Regulatory Commission by October 2021. Shine’s application seeking approval to operate the facility, which will produce isotopes including molybdenum-99, was accepted and docketed by the NRC last October. Mo-99, the precursor to technetium-99m, is used in more than 40 million medical patient procedures every year.
-3 2x1.jpg)
ANS’s first Virtual Trivia Night drew over 80 contestants who were ready to test their nuclear knowledge during an evening of Zoom-based socialization sponsored by the ANS Young Members Group, the Student Sections Committee, and the Diversity and Inclusion in ANS Committee. YMG Vice Chair Catherine Prat hosted the May 8 event. “I really appreciated seeing how engaged the players were throughout the night,” she said. “They were great guinea pigs for this first-of-a-kind event, as we continue to explore ways to connect virtually.”
The ANS Young Members Group (YMG) is delivering an in-depth look at the Department of Energy’s national laboratories through a series of live webinars called Spotlight on National Labs. The third and most recent webinar attracted more than 1,000 participants who were keen to learn about the mission and key projects of Los Alamos National Laboratory.


